← Leaderboards
Tatyana Kushner
Icahn School Of Medicine At Mount Sinai
$1,959,460
Attributed
$1,959,460
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $897.9K · FY2023–25$1M$750K$500K$250K$0
'23
'24
'25
Funding mix
By agency
NIH$1,959,460 · 2
By mechanism
R01$1,387,120 · 1
K23$572,340 · 1
Top collaborators
No co-investigators on record.
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Robert D. Burk$24,637,183
- Nicolas Schlecht$8,465,862
- Angela Diaz$9,604,054
- Maria De Las Mercedes Perez Rodriguez$3,020,700
- Lotje Dorothee De Witte$2,711,041
Others in their field
Other Rising Stars on “Liver Diseases”
- Alexander Kolykhalov · Emory University$8,116,465
- Mark Sorenson · Nirsum Laboratories, Inc.$4,866,388
- Xu Chen · University Of California, San Francisco$3,581,285
- Cindy S Chu · University Of Oxford$3,470,639
- Debanjan Dhar · University Of California, San Diego$3,366,301
- Baodong Sun · Duke University$3,238,660
Research focus
Liver DiseasesPatient PopulationHigh PrevalenceLiverMetabolicPathogenesisEthnic OriginHepaticIncidenceLipidsMaternal MorbidityMaternal MortalityBody Mass IndexNon-Alcoholic Fatty Liver DiseaseAffectDiscipline Of ObstetricsFutureGestational DiabetesHigh RiskHispanicLipid MetabolismLipidomicsAdverse Pregnancy OutcomePolyunsaturated Fatty Acids
Grant awards (6)
Targeting Nonalcoholic Fatty Liver Disease during the reproductive period to improve women's health outcomes$679,731
R01 · FY2025 · DK · contact PI
Nonalcoholic fatty liver disease, associated lipidomic changes, and preeclampsia risk$191,206
K23 · FY2025 · HL · contact PI
Targeting Nonalcoholic Fatty Liver Disease during the reproductive period to improve women's health outcomes$707,389
R01 · FY2024 · DK · contact PI
Nonalcoholic fatty liver disease, associated lipidomic changes, and preeclampsia risk$135,260
K23 · FY2024 · HL · contact PI
Nonalcoholic fatty liver disease, associated lipidomic changes, and preeclampsia risk$55,208
K23 · FY2024 · HL · contact PI
Nonalcoholic fatty liver disease, associated lipidomic changes, and preeclampsia risk$190,666
K23 · FY2023 · HL · contact PI